Scarica l'app Stockscreener
438.15
2.51%
10.71
Dopo l'orario di chiusura:
444.58
6.43
+1.47%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$427.44
Aprire:
$429.99
Volume 24 ore:
2.66M
Relative Volume:
1.31
Capitalizzazione di mercato:
$161.36B
Reddito:
$42.88B
Utile/perdita netta:
$6.34B
Rapporto P/E:
26.51
EPS:
16.53
Flusso di cassa netto:
$7.27B
1 W Prestazione:
+0.05%
1M Prestazione:
-14.79%
6M Prestazione:
-26.60%
1 anno Prestazione:
-23.74%
Intervallo 1D:
$420.00
$440.73
Intervallo di 1 settimana:
$409.85
$455.02
Portata 52W:
$409.85
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Confronta TMO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
438.15 | 161.36B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
188.73 | 129.32B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
390.94 | 30.94B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.71 | 29.30B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
145.55 | 25.25B | 15.41B | 1.37B | 2.11B | 7.50 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
SPONSORED Boys & Girls Clubs and Thermo Fisher Scientific fuel the future of STEM - Axios
Why Thermo Fisher Scientific (TMO) Is One of the Best Medical Stocks to Buy According to Billionaires - Insider Monkey
Bernstein maintains Thermo Fisher stock with $690 target - Investing.com
Ultrasonic Aspirator Market Poised for Rapid Growth, Expected - openPR.com
Nucleic Acid Isolation And Purification Market Generated - openPR.com
Meningitis Diagnostic Testing Market Deep Research Report with - openPR.com
The Zacks Analyst Blog Highlights Eli Lilly, American Express, Thermo Fisher, Steel Partners and Oil-Dri - TradingView
Escherichia Coli Strain Market to Witness Remarkable Growth - openPR.com
Nanorobotics Market Set to Witness Significant Growth - openPR.com
Top Research Reports for Eli Lilly, American Express & Thermo Fisher - Yahoo Finance
Barclays Adjusts Price Target on Thermo Fisher Scientific to $475 From $620 - MarketScreener
Thermo Fisher Scientific Inc (TMO) Trading Down 6.22% on Apr 10 - GuruFocus
Assisted Reproductive Technology Market Forecast Report and Company Analysis 2025-2033 Featuring Thermo Fisher Scientific, Sumitomo Mitsui, CooperSurgical, Fujifilm, Merck, Progyny, Cosmos BiomedicalResearchAndMarkets.com - Bluefield Daily Telegraph
gRNA Market Top Companies StudyThermo Fisher Scientific Inc., - openPR.com
Thermo Fisher (TMO) Surges 8.2%: Is This an Indication of Further Gains? - Nasdaq
Electrocompetent Cells Market Poised to Achieve Robust Growth - openPR.com
Thermo Fisher Scientific, NSG BIO Collaborate to Strengthen Singapore's Biotech Startup Ecosystem - digitimes
Genotyping Assay Market Surges to USD 37.1 Billion by 2029: - openPR.com
Thermo Fisher Scientific Inc. (TMO): Among the High Growth Dividend Paying Stocks to Invest in - Insider Monkey
Earnings Preview: What to Expect From Thermo Fisher Scientific's Report - Nasdaq
Thermo Fisher stock price target cut to $600 at TD Cowen - Investing.com India
Thermo Fisher Scientific releases Krios 5 Cryo-TEM microscope - Scientist Live
Wolfe Research Adjusts PT on Thermo Fisher Scientific to $535 From $665, Maintains Outperform Rating - MarketScreener
Thermo Fisher Scientific, NSG BIO collaborate to strengthen Singapore's biotech startup ecosystem - BioSpectrum Asia
Genomics Market Deep Research Report with Forecast to 2032 | Thermo Fisher Scientific, Inc., Agilent Technologies - openPR.com
New Krios 5 Cryo-TEM from Thermo Fisher delivers up to 25% throughput gain for atomic-resolution analysis - R&D World
Thermo Fisher Scientific launches the Krios 5 Cryo-Transmission Electron Microscope - SelectScience
RBC Cuts Price Target on Thermo Fisher Scientific to $651 From $694, Keeps Outperform Rating - MarketScreener
Japan’s AGC Biologics taps Thermo Fisher for 5,000 L DynaDrive S.U.B.s at Yokohama site - BioSpectrum Asia
Thermo Fisher stock hits 52-week low at $411.46 amid market shifts - Investing.com Canada
Genome Engineering Market to Witness Remarkable Growth with - openPR.com
Thermo Fisher Scientific Declares Quarterly Dividend, payable on October 15, 2019 - BioSpace
Thermo Fisher Scientific Earns Top Score for LGBTQ+ Workplace Equality for Seventh Consecutive Year - MarketScreener
Extracellular Matrix Market Deep Research 2025-2032 | Thermo - openPR.com
Thermo Fisher Scientific launches new IVDR-compliant capillary electrophoresis instrument - SelectScience
Thermo Fisher Stock Benefits From the Launch of Krios 5 Cryo-TEM - Nasdaq
Molecular Diagnostic for Infectious Diseases Market Size to Reach $17.61 Billion by 2030, Driven by Technological Advancements and Rising Global Disease BurdenThe Insight Partners - Yahoo Finance
Thermo Fisher launches centrifuges with next-gen cooling system - Evertiq
Thermo Fisher Scientific Launches the Krios 5 Cryo-Transmission Electron Microscope (TEM), Boosting Productivity and Performance with Enhanced Automation - MSN
Impact of Trump tariffs on med tech proving difficult to anticipate - BioWorld MedTech
Diageo GC Resigns For Top Legal Role At Thermo Fisher - Law360
Exosomes Market Deep Research 2025-2032 | Thermo Fisher - openPR.com
Newborn Calf Serum Market Set to Witness Significant Growth - openPR.com
Evercore ISI Adjusts Thermo Fisher Scientific's Price Target to $585 From $630, Keeps Outperform Rating - MarketScreener
Honeywell appoints Stephen Williamson to board of directors - Engineering.com
Thermo Fisher Scientific Launches the Krios 5 Cryo-Transmission Electron Microscope (TEM), Boosting Productivity and Performance With Enhanced Automation - BioSpace
Thermo Fisher Scientific launches more sustainable centrifuges - SelectScience
Is it Worth Retaining Thermo Fisher Stock in Your Portfolio Now? - Nasdaq
Partnership to develop cell visualisation technology - Scientist Live
Becton Dickinson in talks with Thermo Fisher, Danaher to divest life sciences unit - ET HealthWorld
Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market - MarketWatch
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):